ENTITY
Vectura

Vectura (VEC LN)

7
Analysis
Health CareUnited Kingdom
Vectura Group PLC develops inhaled therapies for the treatment of respiratory diseases. The Company's main products are used to treat asthma and chronic obstructive pulmonary disease. Vectura also develops products for lung pathologies and non-respiratory diseases.
more
bullishVectura
26 Nov 2018 23:08Issuer-paid

Vectura - Not pausing for breath

Building on its positive adjusted H118 EBITDA and its partnerships, Vectura has announced three recent additional developments. Partner Mundipharma...

Share
x